Back to team page

Kaitlin Stinson

Director

Kaitlin brings to Bold Insight over 14 years of experience as a human factors engineer at medical device manufacturers. She has extensive experience in diabetes care products, software as medical device (SaMD), and complex drug delivery systems. Kaitlin has a passion for meeting design control and regulatory requirements while executing agile human factors programs of research. She has a BS in Psychology from Ball State University and an MS in Human Factors from Bentley University.

Bold facts

Learn more about

Kaitlin

Something unique about you summed up in one sentence:

I cycled 2,750 miles in one year.

Your favorite part of working at Bold Insight:

The dynamic, knowledgeable, and fun culture.

In your spare time (or if you had spare time), you would absolutely do this:

Ride my bike or go kayaking.

Your favorite city in the world is...and why?

Indianapolis because that’s where I see my family and friends the most.

You cannot start the day without doing this:

Drinking 40 oz of water.

Your ultimate celebrity dinner party guest list would include:

Bethanny Frankel, Lisa Vanderpump, Gizelle Bryant, & Kyle Richards

Long-term personal or professional goal?

Visit as many wine regions across the globe as possible.

Favorite quote:

“What is the cost of lies? It’s not that we’ll mistake them for the truth. The real danger is that if we hear enough lies, then we no longer recognize the truth at all.” ~ Valery Legasov
Read Kaitlin's bold insights

Read our team’s latest bold insights

The future of fan engagement: How do you measure goosebumps?

Feb 19, 2018

One of the CES presentations I attended was a panel in the sports technology track called, The Future of Fan Engagement. The panel discussed cutting-edge research in the sports tech market and perspectives on the relationship between emergent media technologies and...

read more

The time for a better UX in digital therapeutics is now

Jan 17, 2018

If history has shown that payer behavior tends to shift once a critical mass has been achieved, and we are on the precipice of achieving that critical mass for digital therapeutics, having a “user friendly solution” is about to replace “having a reimbursable solution” as the #1 factor affecting physician prescribing behavior.

read more